Zobrazeno 1 - 10
of 1 111
pro vyhledávání: '"iron chelation therapy"'
Publikováno v:
Thalassemia Reports, Vol 14, Iss 3, Pp 60-70 (2024)
Background: The effective management of iron overload in transfusion-dependent thalassemia (TDT) requires adherence to iron chelation therapy (ICT). However, adherence rates among pediatric thalassemia patients remain suboptimal. This study aimed to
Externí odkaz:
https://doaj.org/article/6fafacceba3e4b34b2725947703ccb5c
Autor:
Sally MacVinish, Crystal van Leeuwen, Maartje Hoetjes, Yoshihiro Aoki, Deirdre Foley, Harriet Roggeveen
Publikováno v:
Conflict and Health, Vol 17, Iss 1, Pp 1-10 (2023)
Abstract Background Thalassaemia affects many families in Northeast Syria, an area devastated by over a decade of conflict which has significantly impacted their health system. People with thalassaemia require holistic multidisciplinary care for the
Externí odkaz:
https://doaj.org/article/46b022e8e70e481f8881d56897b3f88f
Publikováno v:
Annals of Medicine, Vol 54, Iss 1, Pp 326-342 (2022)
Introduction Iron chelation therapy (ICT) is essential to prevent complications of iron overload in patients with transfusion-dependent thalassaemia. However, there is currently no standard for how to best measure adherence to ICT, nor what level of
Externí odkaz:
https://doaj.org/article/d443f16832a64cf8b2b05d68b1675bf5
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Shruti Kakkar, Vaneet Anand, Rashmi Kapoor, Sukhmani Sidhu, Amanat Grewal, Mehak Chawla, J.S. Goraya
Publikováno v:
Pediatric Hematology Oncology Journal, Vol 7, Iss 3, Pp 77-80 (2022)
Introduction: COVID-19 pandemic imposed challenges towards management of transfusion-dependent thalassemia patients (TDT). The need for regular blood transfusions and iron chelation therapy in these patients added further uncertainty about managing C
Externí odkaz:
https://doaj.org/article/5f4ebda9b5504f4e8e6d199c7146dbb1
Publikováno v:
Patient Preference and Adherence, Vol Volume 16, Pp 1423-1437 (2022)
Chinea Eziefula,1,2 Farrukh T Shah,3,4 Kofi A Anie5,6 1Camden & Islington NHS Foundation Trust, London, UK; 2Psychology Services, Whittington Health NHS Trust, London, UK; 3Department of Haematology, Whittington Health NHS Trust, London, UK; 4Medical
Externí odkaz:
https://doaj.org/article/e1eb71a466594510a2a472be7d9ff8d5
Publikováno v:
Pediatric Hematology Oncology Journal, Vol 7, Iss 3, Pp 74-76 (2022)
Introduction: COVID-19 pandemic imposed challenges towards management of transfusion-dependent thalassemia patients (TDT). The need for regular blood transfusions and iron chelation therapy in these patients added further uncertainty about managing C
Externí odkaz:
https://doaj.org/article/d133cbbc70884ed7a5f289afc1837989
Publikováno v:
Journal of Blood Medicine, Vol Volume 12, Pp 1019-1030 (2021)
Sarah Parisi,1 Carlo Finelli2 1IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy; 2IRCCS Azienda Osp
Externí odkaz:
https://doaj.org/article/13fa4193da1b4fd292ba8f964c3b6833
Autor:
Allen Shiun Chat Chai, Nani Draman, Siti Suhaila Mohd Yusoff, Nurul Fatihah Azman, Maryam Mohd Zulkifli, Najib Majdi Yaacob, Norsarwany Mohamad, Rosline Hassan, Wan Zaidah Abdullah, Bin Alwi Zilfalil
Publikováno v:
Pediatric Hematology Oncology Journal, Vol 6, Iss 4, Pp 207-215 (2021)
Aim: To determine the proportion of non-compliance to iron chelation therapy (ICT) and its associated factors amongst patients with transfusion-dependent thalassaemia (TDT) in Malaysia. Methods: A cross-sectional study was conducted amongst patients
Externí odkaz:
https://doaj.org/article/bb2fb85b09004af29ed2798b9293fd31
Autor:
Osama Tanous, Yossi Azulay, Raphael Halevy, Tal Dujovny, Neta Swartz, Raul Colodner, Ariel Koren, Carina Levin
Publikováno v:
BMC Nephrology, Vol 22, Iss 1, Pp 1-11 (2021)
Abstract Background Renal injury in transfusion dependent β thalassemia patients (TDT) has been attributed to iron overload, chronic anemia and iron-chelation therapy (ICT) toxicity. We studied renal function in TDT patients treated with two differe
Externí odkaz:
https://doaj.org/article/81201b27bf3347d9a8c7eebcbfd57449